GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » WIN-Partners Co Ltd (TSE:3183) » Definitions » EPS (Diluted)

WIN-Partners Co (TSE:3183) EPS (Diluted) : 円59.51 (TTM As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is WIN-Partners Co EPS (Diluted)?

WIN-Partners Co's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was 円17.35. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was 円59.51.

WIN-Partners Co's EPS (Basic) for the three months ended in Dec. 2023 was 円17.37. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was 円59.53.

WIN-Partners Co's EPS without NRI for the three months ended in Dec. 2023 was 円17.32. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was 円57.80.

During the past 12 months, WIN-Partners Co's average EPS without NRIGrowth Rate was -2.20% per year. During the past 3 years, the average EPS without NRIGrowth Rate was -1.70% per year. During the past 5 years, the average EPS without NRI Growth Rate was -7.30% per year. During the past 10 years, the average EPS without NRI Growth Rate was 5.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, WIN-Partners Co's highest 3-Year average EPS without NRI Growth Rate was 29.80% per year. The lowest was -76.30% per year. And the median was 2.40% per year.


WIN-Partners Co EPS (Diluted) Historical Data

The historical data trend for WIN-Partners Co's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WIN-Partners Co EPS (Diluted) Chart

WIN-Partners Co Annual Data
Trend Mar12 Mar13 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 91.99 65.23 53.66 63.88 72.04

WIN-Partners Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.50 17.45 10.23 14.48 17.35

Competitive Comparison of WIN-Partners Co's EPS (Diluted)

For the Medical Distribution subindustry, WIN-Partners Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


WIN-Partners Co's PE Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, WIN-Partners Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where WIN-Partners Co's PE Ratio falls into.



WIN-Partners Co EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

WIN-Partners Co's Diluted EPS for the fiscal year that ended in Mar. 2023 is calculated as

Diluted EPS (A: Mar. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(2047.262-0)/28.420
=72.04

WIN-Partners Co's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(495.606-0)/28.566
=17.35

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円59.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


WIN-Partners Co  (TSE:3183) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


WIN-Partners Co EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of WIN-Partners Co's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


WIN-Partners Co (TSE:3183) Business Description

Traded in Other Exchanges
N/A
Address
2-2-1 Kyobashi, Chuoku, 21st Floor, Kyobashi Edogrand, Tokyo, JPN, 104-0031
WIN-Partners Co Ltd is engaged in the healthcare sector. The company provides medical devices to Japan's medical institutions. Its products offerings are Cardiovascular device, Insulin Pump, X-ray Angio System, Carotid Artery Stent, Stent Graft, among others.

WIN-Partners Co (TSE:3183) Headlines

No Headlines